Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Javid Gaziev, Antonella Isgro, MD, Katia Paciaroni, MD, Marco Marziali, MD, Gioia De Angelis, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD

Blood (2018) 132 (Supplement 1): 5777.

https://doi.org/10.1182/blood-2018-99-109764

Published: 2018

Journal Articles

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Javid Gaziev, Antonella Isgrò, MD, Pietro Sodani, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Marziali, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD, Tiziana Gallucci, PhD, Guido Lucarelli, MD

Blood (2017) 130 (Supplement 1): 663.

https://doi.org/10.1182/blood.V130.Suppl_1.663.663

Published: 2017

Journal Articles

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Javid Gaziev, MD, Antonella Isgro, MD, Marco Marziali, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 3468.

https://doi.org/10.1182/blood.V128.22.3468.3468

Published: 2016

Journal Articles

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Javid Gaziev, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Marco Marziali, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 2289.

https://doi.org/10.1182/blood.V128.22.2289.2289

Published: 2016

Journal Articles

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Antonella Isgro, MD, Javid Gaziev, Pietro Sodani, MD, Marco Andreani, PhD, Manuela Testi, PhD, Katia Paciaroni, MD, Cristiano Gallucci, MD, Gioia De Angelis, MD, Marco Marziali, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Olufemi O Akinyanju, T. Thompson Wakama, Festus Olusola Olowoselu, Guido Lucarelli, MD

Blood (2015) 126 (23): 4598.

https://doi.org/10.1182/blood.V126.23.4598.4598

Published: 2015

Journal Articles

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Javid Gaziev, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Pietro Sodani, MD, Marco Marziali, MD, Katia Paciaroni, MD, Marco Andreani, PhD, Manuela Testi, PhD, Cristiano Gallucci, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Maria Troiano, PhD, Aldo Morrone, MD, Guido Lucarelli, MD

Blood (2015) 126 (23): 620.

https://doi.org/10.1182/blood.V126.23.620.620

Published: 2015

Journal Articles

Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach

Javid Gaziev, Marco Marziali, Antonella Isgro, Pietro Sodani, Katia Paciaroni, Cristiano Gallucci, Gioia De Angelis, Cecilia Alfieri, Marco Andreani, BSc, Manuela Testi, Michela Ribersani, Luisa Cardarelli, Daniele Armiento, Guido Lucarelli

Blood (2013) 122 (21): 2040.

https://doi.org/10.1182/blood.V122.21.2040.2040

Published: 2013

Journal Articles

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

Javid Gaziev, Marco Marziali, Antonella Isgrò, Pietro Sodani, Katia Paciaroni, Cristiano Gallucci, Marco Andreani, Manuela Testi, Gioia De Angelis, Cecilia Alfieri, Luisa Cardarelli, Michela Ribersani, Daniele Armiento, Guido Lucarelli

Blood (2013) 122 (15): 2751–2756.

https://doi.org/10.1182/blood-2013-07-513473

Published: 2013

Journal Articles

Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring

Javid Gaziev, Laurent Nguyen, Christian Puozzo, Alessia Francesca Mozzi, Marialuisa Casella, Michela Perrone Donnorso, Paolo Gravina, Pietro Sodani, Marco Marziali, Antonella Isgrò, Maria Domenica Simone, Marco Andreani, Amanda Formosa, Manuela Testi, Giorgio Federici, Sergio Bernardini, Guido Lucarelli

Blood (2010) 115 (22): 4597–4604.

https://doi.org/10.1182/blood-2010-01-265405

Published: 2010

Journal Articles

Purified T-depleted, CD34 + peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia

Blood (2010) 115 (6): 1296–1302.

https://doi.org/10.1182/blood-2009-05-218982

Published: 2010

Journal Articles

Late-Onset Hemorrhagic Cystitis in Children After Hematopoietic Stem Cell Transplantation (HSCT) for Thalassemia and Sickle Cell Anemia: A Prospective Evaluation of Polyoma (BK) Virus Infection and Treatment with Cidofovir (CDV).

Javid Gaziev, Guido Lucarelli, Stefano Germani, Pierpaolo Paba, Carlo Federico Perno, Roberto Miano, Pierluigi Bove, Pietro Sodani, Antonella Isgro, Marco Marziali, Paola Polchi, Aldo Montuoro, Katia Paciaroni, Cristiano Gallucci, Maria Domenica Simone, Andrea Roveda, Gioia De Angelis, Cecilia Alfieri

Blood (2009) 114 (22): 1133.

https://doi.org/10.1182/blood.V114.22.1133.1133

Published: 2009

Journal Articles

Immunological Evaluation after Haematopoietic Stem Cell Transplantation for B–Thalassemia Major

Marco Marziali, Antonella Isgro, Javid Gaziev, Daniela Fraboni, PhD, Paola Polchi, Sr., Pietro Sodani, Cecilia Alfieri, Katia Paciaroni, Cristiano Gallucci, Guido Lucarelli

Blood (2008) 112 (11): 4371.

https://doi.org/10.1182/blood.V112.11.4371.4371

Published: 2008

Journal Articles

Donor’s NK Cells May Influence the Engraftment in Pediatrics Patients after T-Cell Depleted Haploidentical Stem Cell Transplant for Thalassemia

Antonella Isgro, MD, PhD, Marco Marziali, Pietro Sodani, Javid Gaziev, MD, Paola Polchi, Sr., Gioia De Angelis, Daniela Fraboni, PhD, Wilma Leti, MD, Fernando Aiuti, Guido Lucarelli

Blood (2008) 112 (11): 4595.

https://doi.org/10.1182/blood.V112.11.4595.4595

Published: 2008

Journal Articles

Thiotepa in the Conditioning Regimen Decreases Rejection after HLA Identical Allogeneic Marrow Transplantation in Children with Beta Thalassemia Major Aged Less Then 4 Years

Paola Polchi, MD, Javid Gaziev, MD, Guido Lucarelli, Pietro Sodani, Cecilia Alfieri, Gioia De Angelis, Cristiano Gallucci, Antonella Isgro, MD, PhD, Marco Marziali, Andrea Roveda, Katia Paciaroni

Blood (2008) 112 (11): 4598.

https://doi.org/10.1182/blood.V112.11.4598.4598

Published: 2008

Journal Articles

Clinical Outcomes and Pharmacokinetics of Targeted Intravenous Busulfan in Children Receiving Stem Cell Transplantation for Thalassemia.

Blood (2008) 112 (11): 1117.

https://doi.org/10.1182/blood.V112.11.1117.1117

Published: 2008

Journal Articles

Bone Marrow Iron Concentration as a Marker of Iron Accumulation and Marrow Expansion in Patients with Beta Thalassemia Major.

Paola Polchi, Rossella Palmieri, Marco Andreani, Javid Gaziev, MD, Cecilia Alfieri, Gioia De Angelis, Cristiano Gallucci, Antonella Isgro, Marco Marziali, Katia Paciaroni, Andrea Roveda, Pietro Sodani, Guido Lucarelli

Blood (2008) 112 (11): 1852.

https://doi.org/10.1182/blood.V112.11.1852.1852

Published: 2008

Journal Articles

Early T Cell Recovery of Thymus-Derived Naive T Cells and NK Cells in Pediatrics Patients after T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia.

Antonella Isgro’, MD, PhD, Pietro Sodani, MD, Marco Marziali, MD, PhD, Buket Erer, MD, Cecilia Alfieri, MD, Javid Gaziev, MD, Marco Andreani, PhD, Wilma Leti, MD, Massimo Campagna, Fernando Aiuti, MD, Guido Lucarelli, MD

Blood (2007) 110 (11): 3816.

https://doi.org/10.1182/blood.V110.11.3816.3816

Published: 2007

Journal Articles

High Engraftment Rate after Second Stem Cell Transplantation for Thalassemia: A Prospective Study.

Javid Gaziev, MD, Guido Lucarelli, MD, Pietro Sodani, MD, Paola Polchi, MD, Katia Paciaroni, MD, Marco Marziali, MD, Antonella Isgro, MD, Cecilia Alfieri, MD, Maria Domenica Simone, MD, Andrea Roveda, MD, Aldo Montuoro, MD, Gioia De Angelis, MD, Cristiano Gallucci

Blood (2007) 110 (11): 1107.

https://doi.org/10.1182/blood.V110.11.1107.1107

Published: 2007

NARROW

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring

Purified T-depleted, CD34 + peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia

Late-Onset Hemorrhagic Cystitis in Children After Hematopoietic Stem Cell Transplantation (HSCT) for Thalassemia and Sickle Cell Anemia: A Prospective Evaluation of Polyoma (BK) Virus Infection and Treatment with Cidofovir (CDV).

Immunological Evaluation after Haematopoietic Stem Cell Transplantation for B–Thalassemia Major

Donor’s NK Cells May Influence the Engraftment in Pediatrics Patients after T-Cell Depleted Haploidentical Stem Cell Transplant for Thalassemia

Thiotepa in the Conditioning Regimen Decreases Rejection after HLA Identical Allogeneic Marrow Transplantation in Children with Beta Thalassemia Major Aged Less Then 4 Years

Clinical Outcomes and Pharmacokinetics of Targeted Intravenous Busulfan in Children Receiving Stem Cell Transplantation for Thalassemia.

Bone Marrow Iron Concentration as a Marker of Iron Accumulation and Marrow Expansion in Patients with Beta Thalassemia Major.

Early T Cell Recovery of Thymus-Derived Naive T Cells and NK Cells in Pediatrics Patients after T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia.

High Engraftment Rate after Second Stem Cell Transplantation for Thalassemia: A Prospective Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only